Ben Sousa
CIK: 0002013412
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ICU MEDICAL INC/DE
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Aug 12, 2026ICUI
ICU MEDICAL INC/DE
Sale(S)Direct2.3K shares at avg. $178.32$401K - Mar 15, 2026ICUI
ICU MEDICAL INC/DE
Tax Payment(F)Direct718 shares at avg. $125.85$90K - Mar 15, 2026ICUI
ICU MEDICAL INC/DE
Exercise(M)Direct1.3K shares- - Mar 8, 2026ICUI
ICU MEDICAL INC/DE
Tax Payment(F)Direct4K shares at avg. $132.00$524K - Mar 8, 2026ICUI
ICU MEDICAL INC/DE
Exercise(M)Direct7.2K shares- - Mar 8, 2026ICUI
ICU MEDICAL INC/DE
Tax Payment(F)Direct529 shares at avg. $132.00$70K - Mar 8, 2026ICUI
ICU MEDICAL INC/DE
Exercise(M)Direct957 shares- - Mar 7, 2026ICUI
ICU MEDICAL INC/DE
Exercise(M)Direct1.4K shares- - Mar 7, 2026ICUI
ICU MEDICAL INC/DE
Tax Payment(F)Direct782 shares at avg. $132.00$103K - May 15, 2025ICUI
ICU MEDICAL INC/DE
Sale(S)Direct2K shares at avg. $137.36$275K - Mar 15, 2025ICUI
ICU MEDICAL INC/DE
Tax Payment(F)Direct716 shares at avg. $143.45$103K - Mar 15, 2025ICUI
ICU MEDICAL INC/DE
Exercise(M)Direct1.3K shares- - Mar 8, 2025ICUI
ICU MEDICAL INC/DE
Exercise(M)Direct957 shares- - Mar 8, 2025ICUI
ICU MEDICAL INC/DE
Tax Payment(F)Direct550 shares at avg. $141.97$78K - Mar 7, 2025ICUI
ICU MEDICAL INC/DE
Exercise(M)Direct430 shares- - Mar 7, 2025ICUI
ICU MEDICAL INC/DE
Tax Payment(F)Direct260 shares at avg. $141.97$37K - Mar 7, 2025ICUI
ICU MEDICAL INC/DE
Award(A)DirectCommon Stock
4.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | ICUI ICU MEDICAL INC/DE | Sale(S) | 2,250 | $178.32 | $401,209 | Direct |
| Mar 15, 2026 | ICUI ICU MEDICAL INC/DE | Tax Payment(F) | 718 | $125.85 | $90,360 | Direct |
| Mar 15, 2026 | ICUI ICU MEDICAL INC/DE | Exercise(M) | 1,300 | - | $0 | Direct |
| Mar 8, 2026 | ICUI ICU MEDICAL INC/DE | Tax Payment(F) | 3,967 | $132.00 | $523,644 | Direct |
| Mar 8, 2026 | ICUI ICU MEDICAL INC/DE | Exercise(M) | 7,177 | - | $0 | Direct |
| Mar 8, 2026 | ICUI ICU MEDICAL INC/DE | Tax Payment(F) | 529 | $132.00 | $69,828 | Direct |
| Mar 8, 2026 | ICUI ICU MEDICAL INC/DE | Exercise(M) | 957 | - | $0 | Direct |
| Mar 7, 2026 | ICUI ICU MEDICAL INC/DE | Exercise(M) | 1,409 | - | $0 | Direct |
| Mar 7, 2026 | ICUI ICU MEDICAL INC/DE | Tax Payment(F) | 782 | $132.00 | $103,224 | Direct |
| May 15, 2025 | ICUI ICU MEDICAL INC/DE | Sale(S) | 2,000 | $137.36 | $274,714 | Direct |
| Mar 15, 2025 | ICUI ICU MEDICAL INC/DE | Tax Payment(F) | 716 | $143.45 | $102,710 | Direct |
| Mar 15, 2025 | ICUI ICU MEDICAL INC/DE | Exercise(M) | 1,299 | - | - | Direct |
| Mar 8, 2025 | ICUI ICU MEDICAL INC/DE | Exercise(M) | 957 | - | - | Direct |
| Mar 8, 2025 | ICUI ICU MEDICAL INC/DE | Tax Payment(F) | 550 | $141.97 | $78,084 | Direct |
| Mar 7, 2025 | ICUI ICU MEDICAL INC/DE | Exercise(M) | 430 | - | - | Direct |
| Mar 7, 2025 | ICUI ICU MEDICAL INC/DE | Tax Payment(F) | 260 | $141.97 | $36,912 | Direct |
| Mar 7, 2025 | ICUI ICU MEDICAL INC/DE | Award(A) Common Stock | 4,227 | - | - | Direct |
1-17 of 17 transactions
About Sousa Ben
Sousa Ben (SEC CIK 0002013412) files insider reports with the SEC as Chief Information Officer of ICU MEDICAL INC/DE (ICUI).
Signal8 holds 6 ownership filings by Sousa Ben, all Form 4s, filed between Mar 10, 2025 and Aug 12, 2026. Those filings report 17 transactions, from Mar 7, 2025 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sousa Ben's filings is in SAN CLEMENTE, CA.
Recent filings by Sousa Ben
- Aug 12, 2026: Open-market sale of ICUI shares (Form 4, code S).
- Mar 15, 2026: Tax withholding of ICUI shares (Form 4, code F).
- Mar 15, 2026: Option exercise of ICUI shares (Form 4, code M).
- Mar 8, 2026: Tax withholding of ICUI shares (Form 4, code F).
- Mar 8, 2026: Option exercise of ICUI shares (Form 4, code M).
Other insiders filing for ICU MEDICAL INC/DE (ICUI)
- Sanzone Virginia Ruth, VP, General Counsel
- Bonnell Brian Michael, Chief Financial Officer
- Woolson Daniel, VP, GM-Infusion Capital
- Voigtlander Christian B., Chief Operating Officer
- FINNEY ELISHA W, Director
- KENNEDY KOLLEEN T, Director